Abacus Life, INC Form 4 insider transactions

Kevin Scott Kirby, Co-Founder and President of Abacus Life, Inc., sold 75,800 shares of common stock at $8 per share on December 20, 2024.

CEO Jay J. Jackson reports the sale of 75,800 shares and a gift of 625,000 shares of Abacus Life, Inc. common stock.

Abacus Life's Chief Financial Officer, William Hugh McCauley Jr., was granted 125,000 restricted stock units (RSUs) on December 13, 2024, which will vest over three years.

Director Adam Gusky of Abacus Life, Inc. has acquired 10,000 shares of common stock through open market purchases, increasing his total holdings.

Matthew Ganovsky, Co-Founder and President of Abacus Life, reported a transaction involving 757,093 shares of common stock.

Director Adam Gusky of Abacus Life, Inc. has increased his holdings through recent purchases of common stock.

Director Adam Gusky of Abacus Life, Inc. purchased 18,241 shares of common stock at a weighted average price of $7.54 on November 22, 2024.

Abacus Life co-founder and president, Matthew Ganovsky, sold 156,250 shares of common stock at $8 per share on November 21, 2024.

Sean McNealy, Co-Founder and President of Abacus Life, Inc., sold 156,250 shares of common stock at $8 per share on November 21, 2024.

Abacus Life CEO Jay J. Jackson sold 2,031,250 shares of common stock at $8 per share on November 21, 2024, to cover taxes related to vesting restricted stock.

Abacus Life co-founder and president, Kevin Scott Kirby, sold 156,250 shares of common stock at $8 per share on November 21, 2024.

Matthew Ganovsky, Co-Founder and President of Abacus Life, Inc., reported the disposal of 1,589,953 common shares on November 5, 2024.

William McCauley Jr., CFO of Abacus Life, Inc., reports the vesting and conversion of 50,000 Restricted Stock Units (RSUs) into common stock on July 3, 2024.